High pretreatment serum gamma-glutamyl transpeptidase predicts an inferior outcome in nasopharyngeal carcinoma | Zendy

Min Luo | Zendy; Wei Sun | Zendy; Cheng Wu | Zendy; Linli Zhang | Zendy; Dongbo Liu | Zendy; Wenwen Li | Zendy; Qi Mei | Zendy; Guoqing Hu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

High pretreatment serum gamma-glutamyl transpeptidase predicts an inferior outcome in nasopharyngeal carcinoma

Author(s) -

Min Luo,

Wei Sun,

Cheng Wu,

Linli Zhang,

Dongbo Liu,

Wenwen Li,

Qi Mei,

Guoqing Hu

Publication year - 2017

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.18798

Subject(s) - nasopharyngeal carcinoma , medicine , proportional hazards model , univariate analysis , multivariate analysis , hepatocellular carcinoma , gastroenterology , oncology , survival analysis , progression free survival , overall survival , radiation therapy

Gamma-glutamyl transpeptidase (GGT) which plays an important role in tumor initiation, invasion, drug resistance is strongly associated with poor prognosis in patients with cancers. This study was designed to estimate whether pretreatment serum GGT could predict the clinical outcome of nasopharyngeal carcinoma (NPC) patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research